United Therapeutics Corporation: Present at the 41st Annual J.P. Morgan Healthcare Conference
- United Therapeutics Corporation is a biotechnology company focused on the development
- Announced that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will provide an overview
- Update on the company’s business during a fireside chat session at the 41st annual J.P. Morgan Healthcare Conference in San Francisco
- The session will take place on Monday, January 9, 2023, from 1:30 p.m. to 2:10 p.m., Pacific Standard Time
- The recorded version of the session will be available approximately 24 hours after the session ends
- The public benefit purpose is to provide a brighter future for patients through (a) the development
